A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trial.
暂无分享,去创建一个
R. Laing | T. Hickish | S. Ebbs | I. Smith | R. A’Hern | B. Sirohi | M. O'Brien | T. Perren | T. Iveson | A. Skene | G. Coombes | J. Bliss | M. Crawford
[1] F. Schuetz. Adjuvant Systemic Therapy of Breast Cancer , 2011, Breast Care.
[2] E. Winer,et al. International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy , 2009, Journal of the National Cancer Institute.
[3] J. Thigpen. Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer , 2009 .
[4] S. Loibl,et al. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. , 2008, Journal of the National Cancer Institute.
[5] E. Lee,et al. A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer , 2008, Breast Cancer Research and Treatment.
[6] J. Bliss,et al. Improving adjuvant chemotherapy in breast cancer -- can we get more for less with TACT2? , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[7] Mark Norris,et al. The UK Experience , 2005 .
[8] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[9] R. Laing,et al. A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] R. Salazar,et al. Capecitabine named-patient programme for patients with advanced breast cancer , 2002 .
[11] R. Salazar,et al. Capecitabine named-patient programme for patients with advanced breast cancer. the UK experience. , 2001, European journal of cancer.
[12] B. Gusterson,et al. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] T. Hickish,et al. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] D. Talbot,et al. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.